Clinical Trial Update: Weekly Docetaxel and Fixed-Dose Rate Gemcitabine Combination Chemotherapy [Phase 2]

View source ↗

Summary

This document provides an update on a Phase 2 clinical trial evaluating weekly docetaxel in combination with fixed-dose-rate gemcitabine for sarcoma, with the c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcoma

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Asan Medical Center | Conditions: Sarcoma | Phase 2 | Status: UNKNOWN